Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +1.04% | +14.71% | -35.22% |
May. 15 | Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M | MT |
May. 14 | Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.22% | 37.51M | |
-3.15% | 89.69B | |
+3.95% | 41.34B | |
-10.51% | 33.72B | |
+59.06% | 26.11B | |
-20.09% | 14.63B | |
-8.92% | 12.84B | |
-11.46% | 11.66B | |
-43.05% | 11.52B | |
+4.49% | 8.92B |
- Stock Market
- Equities
- FBIO Stock
- News Fortress Biotech, Inc.
- Fortress Biotech Unit Expands Gout Drug License Deal With Fuji Yakuhin to Include New Markets